Citations (18)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Juntao Yan, Yan Wei, Yue Teng, Shimeng Liu, Fuming Li, Shiyi Bao, Yanfeng Ren & Yingyao Chen. (2022) Physician Preferences and Shared-Decision Making for the Traditional Chinese Medicine Treatment of Lung Cancer: A Discrete-Choice Experiment Study in China. Patient Preference and Adherence 16, pages 1487-1497.
Read now
Read now
Jinender Kumar, M Janelle Cambron-Mellott, Tom Tencer, Oliver Will, deMauri S Mackie & Kathleen Beusterien. (2021) Patient and Neurologist Preferences in the United States for Relapsing-Remitting Multiple Sclerosis Treatments: Findings from a Discrete Choice Experiment. Patient Preference and Adherence 15, pages 1515-1527.
Read now
Read now
Martine C Maculaitis, Xianchen Liu, Oliver Will, Madelyn Hanson, Lynn McRoy, Alexandra Berk & Melissa Crastnopol. (2020) Oncologist and Patient Preferences for Attributes of CDK4/6 Inhibitor Regimens for the Treatment of Advanced/Metastatic HR Positive/HER2 Negative Breast Cancer: Discrete Choice Experiment and Best–Worst Scaling. Patient Preference and Adherence 14, pages 2201-2214.
Read now
Read now
Brett Hauber, John R Penrod, David Gebben & Lina Musallam. (2020) The Value of Hope: Patients’ and Physicians’ Preferences for Survival in Advanced Non-Small Cell Lung Cancer. Patient Preference and Adherence 14, pages 2093-2104.
Read now
Read now
Articles from other publishers (14)
Bennet Hensen, Carolin Winkelmann, Frank K. Wacker, Bodo Vogt, Cornelia L. A. Dewald & Thomas Neumann. (2022) Identification of Relevant Attributes for Liver Cancer Therapies (IRALCT): a maximum-difference-scaling analysis. Scientific Reports 12:1.
Crossref
Crossref
Mengqian Zhang, Xiaoning He, Jing Wu, Xinyue Wang, Qian Jiang & Feng Xie. (2022) How Do Treatment Preferences of Patients With Cancer Compare With Those of Oncologists and Family Members? Evidence From a Discrete Choice Experiment in China. Value in Health 25:10, pages 1768-1777.
Crossref
Crossref
Ute Lewitzka, Joana Anjo, Tiina Annus, Stephane Borentain, Kirsty Hope, Andrew Major, Marguerite O'Hara & Maurizio Pompili. (2022) Treatment patterns and decision drivers to discharge patients with depression hospitalised for acute suicidal ideation in Europe. Journal of Affective Disorders 311, pages 614-621.
Crossref
Crossref
Ann Livingstone, Kathy Dempsey, Martin R. Stockler, Kirsten Howard, Georgina V. Long, Matteo S. Carlino, Alexander M. Menzies & Rachael L. Morton. (2021) Adjuvant immunotherapy recommendations for stage III melanoma: physician and nurse interviews. BMC Cancer 21:1.
Crossref
Crossref
Carol Mansfield, Kelley Myers, Kathleen Klein, Jeetvan Patel, Antonio Nakasato, You-Li Ling & Ahmad A Tarhini. (2021) Risk tolerance in adjuvant and metastatic melanoma settings: a patient perspective study using the threshold technique. Future Oncology 17:17, pages 2151-2167.
Crossref
Crossref
Juliane Weilandt, Katharina Diehl, Marthe‐Lisa Schaarschmidt, Felix Kiecker, Bianca Sasama, Melanie Pronk, Jan Ohletz, Andreas Könnecke, Verena Müller, Jochen Utikal, Uwe Hillen, Wolfgang Harth & Wiebke K. Peitsch. (2021) Patientenpräferenzen für die Therapie fortgeschrittener Melanome: Einfluss von Komorbidität. JDDG: Journal der Deutschen Dermatologischen Gesellschaft 19:1, pages 58-72.
Crossref
Crossref
Juliane Weilandt, Katharina Diehl, Marthe‐Lisa Schaarschmidt, Felix Kiecker, Bianca Sasama, Melanie Pronk, Jan Ohletz, Andreas Könnecke, Verena Müller, Jochen Utikal, Uwe Hillen, Wolfgang Harth & Wiebke K. Peitsch. (2020) Patient preferences for treatment of advanced melanoma: impact of comorbidities. JDDG: Journal der Deutschen Dermatologischen Gesellschaft 19:1, pages 58-70.
Crossref
Crossref
Bruce Feinberg, Skyler Hime, Jeff Wojtynek, Igoni Dokubo, Ajeet Gajra, Yolaine Smith & Jonathan Kish. (2020) Physician treatment of metastatic triple-negative breast cancer in the immuno-oncology era: a discrete choice experiment. Future Oncology 16:33, pages 2713-2722.
Crossref
Crossref
Cameron M. Phillips, Ken Deal, Melanie Powis, Simron Singh, Laavanya Dharmakulaseelan, Harsh Naik, Aditi Dobriyal, Nasrin Alavi & Monika K. Krzyzanowska. (2020) Evaluating Patients’ Perception of the Risk of Acute Care Visits During Systemic Therapy for Cancer. JCO Oncology Practice 16:7, pages e622-e629.
Crossref
Crossref
Francesco Patalano, Florian S. Gutzwiller, Bhavik Shah, Chitresh Kumari & Nigel S. Cook. (2019) Gathering Structured Patient Insight to Drive the PRO Strategy in COPD: Patient-Centric Drug Development from Theory to Practice. Advances in Therapy 37:1, pages 17-26.
Crossref
Crossref
Yukie Omori, Sotaro Enatsu, Zhihong Cai & Hiroshi Ishiguro. (2019) Patients’ preferences for postmenopausal hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer treatments in Japan. Breast Cancer 26:5, pages 652-662.
Crossref
Crossref
Carol Mansfield, Briana Ndife, Joyce Chen, Kathleen Gallaher & Sameer Ghate. (2019) Patient preferences for treatment of metastatic melanoma. Future Oncology 15:11, pages 1255-1268.
Crossref
Crossref
Hayley M. de Freitas, Tetsuro Ito, Monica Hadi, Gemma Al-Jassar, Mickaël Henry-Szatkowski, Beenish Nafees & Andrew J. Lloyd. (2019) Patient Preferences for Metastatic Hormone-Sensitive Prostate Cancer Treatments: A Discrete Choice Experiment Among Men in Three European Countries. Advances in Therapy 36:2, pages 318-332.
Crossref
Crossref
Richard W Joseph, Alicia C Shillington, Cynthia Macahilig, Scott J Diede, Vaidehi Dave, Qing Harshaw & Frank Xiaoqing Liu. (2018) Factors associated with immunotherapy selection in patients with advanced melanoma. Immunotherapy 10:16, pages 1361-1369.
Crossref
Crossref